Status:
COMPLETED
Effects of Whole-body Vibration Therapy on Type 2 Diabetic Patients with and Without Polyneuropathy
Lead Sponsor:
Pamukkale University
Conditions:
Type 2 Diabetes
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
The aim of this study is to show how whole body vibration training practiced for 12 weeks affects the levels of inflammatory biomarkers such as C reactive protein (CRP) and, interleukin-6 (IL-6), in T...
Detailed Description
Volunteers with type 2 diabetes mellitus with and without peripheric neuropathy will be evaluated in terms of any contra-indication that will restrain them from making exercise with whole body vibrati...
Eligibility Criteria
Inclusion
- Participants must stand and walk o without using an assistive device.
- Participants must have a weight of less than 120 kg.
Exclusion
- T2DM patients with advanced cardiovascular, renal, hepatic disease
- T2DM patients with diabetic retinopathy or nephropathy
- T2DM patients with untreated hypertension, rhythm disorders, and those who have undergone bypass surgery
- T2DM patients with ischemic changes in the resting ECG
- T2DM patients with untreated hypoglycemia or orthostatic hypotension
- T2DM patients who are unable to walk independently, or use of canes, crutches or wheelchairs
- T2DM patients who have open ulcers or wounds on load-bearing surfaces
- T2DM patients with inflammatory rheumatic diseases such as rheumatoid arthritis
- T2DM patients with active infectious disease
- T2DM patients with high risk of thrombosis, those with deep vein thrombosis
- T2DM patients who carry a pacemaker, prosthesis, intrauterine device or metal implant,
- T2DM patients with a history of cancer
- T2DM patients with severe migraine, epilepsy, stroke or other neurological disorders, those who have undergone brain surgery
- T2DM patients with non-diabetic neuropathy due to reasons such as HIV, AIDS, alcohol, uremia
- T2DM patients with cognitive impairment
- T2DM patients who are on psychotropic or neurotoxic therapy
- T2DM patients with advanced balance problems
- T2DM patients who are pregnant or breastfeeding mothers
- T2DM patients who are organ transplant recipients
- T2DM patients with hernia
- T2DM patients with kidney or bladder stones
- T2DM patients who are exposed to mechanical vibration due to their job
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06033508
Start Date
April 1 2024
End Date
November 1 2024
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamukkale University
Denizli, Denizli, Turkey (Türkiye), 21600